Symbiosis Expands Sterile Manufacturing Capacity with £26m Investment

        Symbiosis Pharmaceutical Services is entering a new phase of growth following a £26 million investment to expand its ...

September 23, 2026 | Wednesday | Interview
NorahLux Launches Research Hub Covering More Than 10,000 Red Light Therapy Studies

NorahLux has launched the Red Light Therapy Research Hub, an interactive research tool designed to make studies on photobiomodulation easier to search an...

September 22, 2026 | Tuesday | News
Novartis Receives Positive CHMP Opinion for Cosentyx in Polymyalgia Rheumatica

Novartis announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion r...

September 21, 2026 | Monday | News
Boehringer Ingelheim Launches PED Essentials to Strengthen Patient Experience Data

Ingelheim, Germany - Boehringer Ingelheim announced the launch of PED Essentials, a comprehensive e-learning hub designed to help patient organizations g...

September 18, 2026 | Friday | News
Seeing Biologics in Action: The Next Frontier in Analytical Science

  As biologics and novel modalities become increasingly sophisticated, understanding molecular structure under controlled conditions tells only part ...

September 17, 2026 | Thursday | Interaction
Scaling Biopharma Without Compromising Quality

  For emerging biopharma companies, speed, quality and scalability cannot be treated as separate priorities. As products progress t...

September 17, 2026 | Thursday | Interaction
MaaT Pharma Faces Negative CHMP Trend for MaaT013 aGvHD Application

MaaT Pharma was informed of a negative trend during the Committee for Medicinal Products for Human Use (CHMP)’s Oral Explanation meeting which ...

September 16, 2026 | Wednesday | News
Sygnature Discovery Formalises X-Chem Collaboration to Expand DNA-Encoded Library Screening

Sygnature Discovery, a leading integrated drug discovery contract research organisation (CRO), has established a formal collaboration with X-Chem, a data...

September 16, 2026 | Wednesday | News
Roche and MediLink Report Positive Phase III Tam-Peli Data in Relapsed Small-Cell Lung Cancer

Tambotatug pelitecan (Tam-Peli) demonstrated statistically significant efficacy over topotecan in a phase III study conducted in China, reducing the ri...

September 14, 2026 | Monday | News
Seismic Pharmaceuticals Enrols First Patient in Global Phase III Istaroxime Trial for Cardiogenic Shock

Approximately 600 patients expected to be enrolled at clinical sites across the United States, Europe, China and South America Global Phase 3 program, R...

September 11, 2026 | Friday | News
Novartis’ Del-Desiran Misses Phase III HARBOR Primary Endpoint in DM1

HARBOR did not meet its primary endpoint of vHOT in DM1, a progressive neuromuscular disease with high unmet need and no approved treatment options ...

September 09, 2026 | Wednesday | News
Novartis Pelacarsen Phase III Trial Fails to Reduce Cardiovascular Events

Novartis announced that the pelacarsen phase III Lp(a)HORIZON trial, a pioneering cardiovascular outcomes study, did not meet its primary endpoint of red...

September 08, 2026 | Tuesday | News
Mabwell Reports Positive Phase Ib/IIa Results for Anti-ST2 Antibody 9MW1911 in COPD

Mabwell, an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced the Phase Ib/IIa clinical results of its anti-S...

September 07, 2026 | Monday | News
Resonant Clinical Solutions Acquires Creapharm Bioservices to Expand European Biorepository Capabilities

Resonant Clinical Solutions, a global clinical solutions partner serving life sciences organizations across the clinical supply chain and sample lifecycl...

September 07, 2026 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close